Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-21-146396

SVP, Chief Business Officer sold 27,500 shares at $3.96 ($108,900)

  • SVP, Chief Business Officer acquired 27,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Korbel Gregory Alan SVP, Chief Business Officer 2021-12-01 Option exercise +27,500 $0.92 $25,300 44,667 D
Korbel Gregory Alan SVP, Chief Business Officer 2021-12-01 Sale −27,500 $3.96 $108,900 17,167 D
Derivatives
Korbel Gregory Alan SVP, Chief Business Officer 2021-12-01 Option exercise · Stock Option (right to Buy) −27,500 2,335 D
Open-market sales · 27,500 sh · avg $3.96 · $108,900
Loading xslF345X03/tm2134490-1_4seq1.xml…